| Year |
Citation |
Score |
| 2022 |
Nguyen TT, Shin DH, Sohoni S, Singh SK, Rivera-Molina Y, Jiang H, Fan X, Gumin J, Lang FF, Alvarez-Breckenridge C, Godoy-Vitorino F, Zhu L, Zheng WJ, Zhai L, Ladomersky E, et al. Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry. Journal For Immunotherapy of Cancer. 10. PMID 35902132 DOI: 10.1136/jitc-2022-004935 |
0.337 |
|
| 2020 |
Alvarez-Breckenridge C, Markson S, Stocking J, Lastrapes M, Nayyar N, Bertalan M, Kaplan A, Alvarez MM, Izar B, Suva M, Sullivan R, Cahill D, Carter S, Brastianos P. IMMU-01. SINGLE CELL SEQUENCING OF MELANOMA BRAIN METASTASES UNVEILS HETEROGENEITY OF THE TUMOR MICROENVIRONMENT IN RESPONSE TO IMMUNE CHECKPOINT BLOCKADE Neuro-Oncology. 22: ii104-ii104. DOI: 10.1093/neuonc/noaa215.432 |
0.307 |
|
| 2017 |
Brastianos PK, Alvarez-Breckenridge C, Miller JJ, Nayyar N, Gill C, Dias-Santagata D, Santagata S, Multani P, Yip S, Cahill D, Iafrate AJ, Batchelor T. OS06.4 Identification of novel NTRK fusion in glioneuronal tumors and radiographic response following therapy with an NTRK inhibitor Neuro-Oncology. 19: iii11-iii11. DOI: 10.1093/Neuonc/Nox036.038 |
0.301 |
|
| 2016 |
Bolyard CM, Meisen WH, Banasavadi-Siddegowda Y, Hardcastle J, Yoo JY, Wohleb ES, Wojton J, Yu JG, Dubin S, Khosla M, Xu B, Smith JG, Alvarez-Breckenridge C, Pow-Anpongkul P, Pichiorri F, et al. BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection- implications for Oncolytic Viral Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27852701 DOI: 10.1158/1078-0432.Ccr-16-1818 |
0.637 |
|
| 2015 |
Suryadevara CM, Gedeon PC, Sanchez-Perez L, Verla T, Alvarez-Breckenridge C, Choi BD, Fecci PE, Sampson JH. Are BiTEs the "missing link" in cancer therapy? Oncoimmunology. 4: e1008339. PMID 26155413 DOI: 10.1080/2162402X.2015.1008339 |
0.301 |
|
| 2015 |
Alvarez-Breckenridge CA, Choi BD, Suryadevara CM, Chiocca EA. Potentiating oncolytic viral therapy through an understanding of the initial immune responses to oncolytic viral infection. Current Opinion in Virology. 13: 25-32. PMID 25846988 DOI: 10.1016/J.Coviro.2015.03.015 |
0.381 |
|
| 2015 |
Alvarez-Breckenridge CA, Choi BD, Suryadevara CM, Chiocca EA. Potentiating oncolytic viral therapy through an understanding of the initial immune responses to oncolytic viral infection Current Opinion in Virology. 13: 25-32. DOI: 10.1016/j.coviro.2015.03.015 |
0.417 |
|
| 2014 |
Kaur B, Meisen WH, Hardcastle J, Wojton J, Wohleb E, Alvarez-Breckenridge C, Pow-anpongkul P, Godbout J. Vstat120 Reduces The Innate Inflammatory Response To Infection And Enhances Oncolytic Viral Therapy For Glioblastoma. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou209.2 |
0.776 |
|
| 2013 |
Alvarez-Breckenridge CA, Yu J, Caligiuri MA, Chiocca EA. Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy. Oncoimmunology. 2: e23658. PMID 23734319 DOI: 10.4161/Onci.23658 |
0.363 |
|
| 2013 |
Price RL, Song J, Bingmer K, Kim TH, Yi JY, Nowicki MO, Mo X, Hollon T, Murnan E, Alvarez-Breckenridge C, Fernandez S, Kaur B, Rivera A, Oglesbee M, Cook C, et al. Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Cancer Research. 73: 3441-50. PMID 23729642 DOI: 10.1093/Neuonc/Nou206.27 |
0.584 |
|
| 2012 |
Alvarez-Breckenridge CA, Yu J, Price R, Wojton J, Pradarelli J, Mao H, Wei M, Wang Y, He S, Hardcastle J, Fernandez SA, Kaur B, Lawler SE, Vivier E, Mandelboim O, et al. NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors. Nature Medicine. 18: 1827-34. PMID 23178246 DOI: 10.1038/Nm.3013 |
0.695 |
|
| 2012 |
Yoo JY, Pradarelli J, Haseley A, Wojton J, Kaka A, Bratasz A, Alvarez-Breckenridge CA, Yu JG, Powell K, Mazar AP, Teknos TN, Chiocca EA, Glorioso JC, Old M, Kaur B. Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4931-41. PMID 22753591 DOI: 10.1158/1078-0432.Ccr-12-0697 |
0.677 |
|
| 2012 |
Alvarez-Breckenridge CA, Yu J, Price R, Wei M, Wang Y, Nowicki MO, Ha YP, Bergin S, Hwang C, Fernandez SA, Kaur B, Caligiuri MA, Chiocca EA. The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon. Journal of Virology. 86: 4566-77. PMID 22318143 DOI: 10.1128/Jvi.05545-11 |
0.648 |
|
| 2012 |
Alvarez-Breckenridge CA, Yu J, Kaur B, Caligiuri MA, Chiocca EA. Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells. Advances in Virology. 2012: 702839. PMID 22312364 DOI: 10.1155/2012/702839 |
0.637 |
|
| 2012 |
Yang FH, Zhang B, Zhou DJ, Bie L, Tom MW, Drummond DC, Nicolaides T, Mueller S, Banerjee A, Park JW, Prados MD, James DC, Gupta N, Hashizume R, Strohbehn GW, ... ... Alvarez-Breckenridge C, et al. LAB-EXPERIMENTAL (PRE-CLINICAL) THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 14: vi25-vi37. DOI: 10.1093/Neuonc/Nos222 |
0.677 |
|
| 2011 |
Pavel H, Ajeawung N, Faure R, Poirier D, Kamnasaran D, Ajeawung N, Joshi H, Kamnasaran D, Poirier D, Ajeawung N, Kamnasaran D, Lun X, Zemp F, Sun B, Stechishin O, ... ... Alvarez-Breckenridge C, et al. PRECLINICAL EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY Neuro-Oncology. 13: iii107-iii120. DOI: 10.1093/Neuonc/Nor158 |
0.446 |
|
| 2010 |
Alvarez-Breckenridge CA, Yu J, Pradarelli J, Liu T, Kaur B, Caligiuri M, Chiocca EA. Abstract 1514: Oncolytic viral therapy for glioblastoma induces robust natural killer cell activation Cancer Research. 70: 1514-1514. DOI: 10.1158/1538-7445.Am10-1514 |
0.639 |
|
| 2010 |
Kaka A, Pradarelli JC, Alvarez-Breckenridge C, Yoo JY, Pan Q, Chiocca EA, Old M, Teknos T, Kaur B. Abstract 1383: The effect of a novel angiogenesis inhibitor (TM) on the efficacy of HSV-1 oncolytic virus Cancer Research. 70: 1383-1383. DOI: 10.1158/1538-7445.Am10-1383 |
0.623 |
|
| 2009 |
Alvarez-Breckenridge C, Kaur B, Chiocca EA. Pharmacologic and chemical adjuvants in tumor virotherapy. Chemical Reviews. 109: 3125-40. PMID 19462957 DOI: 10.1021/Cr900048K |
0.65 |
|
| 2009 |
Haseley A, Alvarez-Breckenridge C, Chaudhury AR, Kaur B. Advances in oncolytic virus therapy for glioma. Recent Patents On Cns Drug Discovery. 4: 1-13. PMID 19149710 DOI: 10.2174/157488909787002573 |
0.794 |
|
| Show low-probability matches. |